We have located links that may give you full text access.
Hydroxamic acid mediated heterogeneous Fenton-like catalysts for the efficient removal of Acid Red 88, textile wastewater and their phytotoxicity studies.
Ecotoxicology and Environmental Safety 2018 October 24
Heterogeneous Fenton-like catalyst and its industrial application are increasingly given importance for its non-selective mineralization of organic pollutants in broad pH range. Current study, utilized an aromatic hydroxamic acid derivative 2-hydroxypyridine-N-oxide (HpO), for the construction of iron-Hpo ligand catalyst supported on granular activated carbon (GAC). 8-Hydroxyquinoline and citric acid as non-hydroxamic aromatic and aliphatic Fenton-like catalysts were used for comparative evaluation of the efficiency with targeted catalyst (iron-HpO-GAC). This novel catalyst iron-HpO-GAC exhibits excellent efficiency in Acid Red 88 dye removal in the presence of hydrogen peroxide as oxidant at acidic, basic as well as at neutral conditions. Operational conditions for the catalytic oxidation including temperature, dye concentration, pH and catalyst dosage were systematically investigated and analyzed through kinetic studies. Thermodynamic analysis of the catalytic dye removal revealed that the system could oxidize pollutants faster with less activation energy requirement. Higher level of recyclability and stability of the catalyst with less iron leaching was achieved. Finally, the real time application of the catalyst was investigated through successful repeated treatment for actual industrial wastewater. The phytotoxicity assay (with respect to plant Phaseolus mungo) revealed that the degradation of Acid Red 88 and dye wastewater produced nontoxic metabolites which increases its potential application. This study emphasizes the viability of hydroxamate mediated efficient Fenton-like oxidation as a novel approach in designing economically viable pollutant removal technology.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app